Fig. 2From: Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patientsSerum IL-36α and IL-36γ levels in myasthenia gravis (MG) in the acute and remission phases. a Comparison of serum IL-36α levels between MG patients in the acute and remission phases. b Comparison of serum IL-36γ levels between MG patients in the acute and remission phasesBack to article page